Søren Flensted Lassen

Title: Søren Flensted Lassen: Innovator in Endoglucanase Technology

Introduction

Søren Flensted Lassen is a notable inventor based in Farum, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides with endoglucanase activity. With a total of 5 patents to his name, Lassen's work has advanced the understanding and application of these important biological molecules.

Latest Patents

Lassen's latest patents focus on isolated polypeptides that exhibit endoglucanase activity. These patents also include isolated polynucleotides that encode these polypeptides. The inventions encompass nucleic acid constructs, vectors, and host cells that incorporate the polynucleotides. Furthermore, they detail methods for producing and utilizing the polypeptides, showcasing the practical applications of his research.

Career Highlights

Throughout his career, Søren Flensted Lassen has worked with prominent companies in the biotechnology sector, including Novozymes A/S and Novozymes, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to innovative projects that push the boundaries of biotechnology.

Collaborations

Lassen has had the opportunity to work alongside talented individuals such as Paul Vincent Harris and Elena Vlasenko. These collaborations have enriched his research and fostered a dynamic exchange of ideas within the scientific community.

Conclusion

Søren Flensted Lassen's contributions to the field of biotechnology, particularly through his patents on endoglucanase activity, highlight his role as an influential inventor. His work continues to impact the industry and advance scientific knowledge.